Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
about
Modulation of host lipid metabolism by hepatitis C virus: Role of new therapiesChronic hepatitis C virus infection and lipoprotein metabolismCell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5AHepatitis C virus life cycle and lipid metabolismEffect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles.Plasma triglyceride levels may modulate hepatitis C viral replication.Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation.Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.
P2860
Q26782009-42520532-294E-4296-9CF5-9DE50EFB8EBDQ26784234-A91DDEC7-F67A-4338-8599-9B585983E750Q27469080-4B15E3C9-A560-4709-9525-4499EB5FEC99Q34792436-E9FF8DEE-E7B4-40BF-A213-6F4EF9FB4580Q35122536-8AE58DC9-ADFB-4B51-9DE3-9A5FFCC3E16BQ35757377-A621A495-8984-4EE2-A4D2-6A192F12CB02Q36010861-E78CF654-4CB7-43EC-8541-25EAB95D1A7EQ37015738-1F217D71-86F6-4FC8-884B-F5796172A810Q38166372-0D62C4D1-FF35-42E8-80B8-5EC9E8F5FA35Q38728564-51B6455D-C1DA-4CB8-9BF3-29AAACAC281BQ38743914-3AEA450C-D861-4D66-AA7F-8387728D25FAQ39380623-14888207-0590-4597-8BAE-BBC6F69BD192Q40348492-3323C73D-6930-4895-B6FB-B2BEFB887FD6Q42235591-375A248B-8293-44A0-851E-EB10B99DE485Q47547562-BD491244-B53B-4CED-865A-47605FF003CAQ55513556-AF0A2AD0-9BD1-4ED4-90F9-2BEB2382DFC1
P2860
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@en
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@nl
type
label
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@en
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@nl
prefLabel
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@en
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@nl
P2093
P2860
P1433
P1476
Very low-density lipoprotein/l ...... tion via apolipoprotein C-III.
@en
P2093
Chun-Chieh Lin
Dar-Bin Shieh
Hung-Yu Sun
Jin-Ching Lee
Kung-Chia Young
Ming-Derg Lai
Pin-Nan Cheng
Shainn-Wei Wang
Ting-Tsung Chang
P2860
P304
P356
10.1136/GUTJNL-2011-301798
P407
P577
2012-06-11T00:00:00Z